FIRST AMENDMENT TO CLINICAL AND COMMERCIAL SUPPLY AGREEMENTClinical and Commercial Supply Agreement • August 7th, 2020 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations
This FIRST AMENDMENT TO CLINICAL AND COMMERCIAL SUPPLY AGREEMENT is entered into as of June 12, 2020 (this “First Amendment”), by and between Aclaris Therapeutics, Inc., a Delaware corporation (“Aclaris”), and PeroxyChem LLC, a Delaware limited liability company (“PeroxyChem”). Aclaris and PeroxyChem are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
CLINICAL AND COMMERCIAL SUPPLY AGREEMENTClinical and Commercial Supply Agreement • August 17th, 2015 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS CLINICAL AND COMMERCIAL SUPPLY AGREEMENT (this “Agreement”), effective as of August 6, 2014 (“Effective Date”), by and between PeroxyChem, a Delaware corporation, with a principal place of business at 1735 Market Street, Philadelphia, Pennsylvania 19103 (“PeroxyChem”) and Aclaris Therapeutics, Inc., a Delaware corporation, with a principal place of business at 101 Lindenwood Drive, Suite 400, Malvern, Pennsylvania 19355 (“Aclaris”).
Clinical and Commercial Supply Agreement Viral Vector Product by and between bluebird bio, Inc. and SAFC Carlsbad, Inc. November 27, 2017Clinical and Commercial Supply Agreement • August 1st, 2019 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Clinical and Commercial Supply Agreement (this “Agreement”), executed as of November 27, 2017 and effective as of January 1, 2018 (the “Effective Date”), is entered into by and between:
Restated and Amended Toll Manufacturing Agreement by and among Gilead Sciences Limited Unit 13, Stillorgan Industrial Park Blackrock, Co. Dublin, Ireland Gilead Sciences, Inc. Foster City, CA 94404 USA and ALTANA Pharma Oranienburg GmbH Lehnitzstr....Clinical and Commercial Supply Agreement • March 3rd, 2006 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
This Restated and Amended And Restated Clinical and Commercial Supply Agreement (the “Agreement”) is entered into and made effective as of November 7, 2005 (the “Effective Date”) among, on the one hand, Gilead Sciences Limited., an Irish limited Company (“GSL”), whose registered address is Unit 13, Stillorgan Industrial Park, Blackrock, Co. Dublin, Ireland, and Gilead Sciences, Inc, a Delaware corporation (“GSI”) with its principal office located at 333 Lakeside Drive, Foster City, CA 94404, USA (Gilead World and Gilead Sciences collectively, “GILEAD”), and, on the other hand, Altana Pharma Oranienburg GmbH, a German corporation (“APO”) having its principal place of business at Lehnitzstrasse 70-98, 16515 Oranienburg, Germany. Gilead and APO are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
